Peptide data sheet
KLOW Stack
Skincare · KLOW · KLOW blend
Verdict
unprovenThe unproven label is about the STACK: while individual components like GHK-Cu carry real topical cosmetic data, no controlled study has tested the KLOW combination as a combination, so its stack-level benefits and interactions are not established.
Quick answer
KLOW is a research-grade blend of four peptides — GHK-Cu, KPV, BPC-157, and TB-500 — commonly researched for skin and tissue-repair interest. Each part has its own evidence base (strongest for topical GHK-Cu), but the KLOW stack itself has never been tested as a stack in humans, and its components are not FDA-approved. It is sold for laboratory research use only.
- Class
- Multi-peptide blend (GHK-Cu + KPV + BPC-157 + TB-500)
- Half-life
- not characterized for the blend (components differ; reported)
- FDA status
- Not FDA-approved. KLOW and each of its components are sold for laboratory research use only and are not approved for human use.
- WADA banned?
- Yes
Which form actually works?
Blended vial (research-grade)
Unproven
The way KLOW is typically sold — the four peptides pre-combined. Convenient, but the convenience is the point: no study has evaluated this specific four-part combination as a whole, so its stack-level picture is inferred from the separate parts, not measured.
Individual components studied separately
Promising
The parts have more research context on their own than the blend does. Topical GHK-Cu in particular carries real human cosmetic data. But separate-component evidence is not the same as evidence for the stack, and one component (TB-500) is on the WADA banned list.